Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U3LK
|
||||
Former ID |
DIB014097
|
||||
Drug Name |
Metformin glycinate
|
||||
Synonyms |
DMMET-01; Metformin glycinate (diabetes); Type 2 diabetes therapy, Laboratorios Silanes; Metformin glycinate (diabetes), Laboratorios Silanes
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 2/3 | [522727] | ||
Company |
Laboratorios Silanes SA De CV
|
||||
Structure |
Download2D MOL |
||||
Formula |
C6H16N6O2
|
||||
Canonical SMILES |
C(=N)(NC(=N)N)N(C)C.C(=O)(CN)O
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Insulin receptor | Target Info | Inhibitor | [544283] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
cGMP-PKG signaling pathway | |||||
HIF-1 signaling pathway | |||||
FoxO signaling pathway | |||||
PI3K-Akt signaling pathway | |||||
AMPK signaling pathway | |||||
Adherens junction | |||||
Insulin signaling pathway | |||||
Ovarian steroidogenesis | |||||
Type II diabetes mellitus | |||||
Non-alcoholic fatty liver disease (NAFLD) | |||||
Aldosterone-regulated sodium reabsorption | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Insulin Pathway | ||||
Signaling events mediated by PTP1B | |||||
Signaling events mediated by TCPTP | |||||
Insulin-mediated glucose transport | |||||
PathWhiz Pathway | Insulin Signalling | ||||
Leucine Stimulation on Insulin Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.